Yeah-- I think that those of us with
daughters probably have a hard time understanding just how much better the AuviQ is for teenaged BOYS.
The smaller size and more discreet carrying possibilities are hard to overstate for that age group.
Dey/Mylan have demonstrated that they simply don't really
care that much about what research-research (as opposed to poorly selected MARKET research) suggests is The Single Biggest Problem with the highest risk age cohort--
they don't CARRY autoinjectors.While the powers that be at Mylan have been busy trying to ADVERTISE their way out of this by targeting the
parents of preschoolers, those of us who have been FA advocates and parent-coaches in this community for years are left scratching our heads-- because THAT doesn't solve the real problem. We all know WHY boys don't self-carry in their teens, and it's mind-boggling to consider that the device-maker does
not. But apparently this is true. They've chosen to advertise to parents of 0-5yo, and sell a lot more devices to this cohort. Without actually improving fatality stats in teens.
If I sound bitter, read through the food allergy death thread a bit. Adolescents MUST self-carry if those stats are
ever going to change. They aren't going to do that if "self-carry" means "hang a big old sign around my neck that says I'm a freak."
So yeah-- Epipen's redesign was an EPIC fail there; it made the devices larger, and did NOTHING to improve the profile for more discreet self-carry. Not that big a problem for girls and women, just continue sizing purse/bag purchases with devices in hand, YK? But the issue for guys is even worse than it's ever been.